
Authorization To Release Confidential Substance Use Disorder Treatment
Use a Authorization To Release Confidential Substance Use Disorder Treatment 2017 template to make your document workflow more streamlined.
Who uses this release authorization
Healthcare providers
Behavioral health providers use the authorization to document a patient’s permission before sharing specified substance use disorder treatment information with a named person, organization, or care participant.
Patients and representatives
Patients and authorized representatives review the permitted information, recipient, purpose, expiration, and signature fields before approving the release electronically.
Features for treatment-release authorizations
signNow combines field preparation, role-based signing, audit evidence, mobile access, and controlled storage for this sensitive authorization workflow.
Fillable fields
Complete the authorization electronically, capture required signatures, and reduce manual transcription before treatment information is released to an approved recipient.
Role assignment
Assign patient, provider, and recipient roles so each participant receives only the fields and signing actions relevant to the authorization.
Audit trail
Capture timestamps, signer actions, and completion history in an audit trail that can support later review of the signed release.
Mobile signing
Use mobile apps for review and signing when authorized representatives cannot complete the form from a desktop workstation.
Controlled storage
Store the completed authorization with controlled access so confidential substance use disorder treatment information is not distributed through unmanaged files.
System connections
Connect completed records with approved business systems using signNow integrations such as Box, Google Drive, Salesforce, or NetSuite.
How this authorization moves through signNow
The signNow workflow turns a completed treatment-release authorization into a controlled, reviewable electronic record.
Upload form: Upload the authorization and review detected fields. Assign roles: Add patient, provider, and recipient signing roles. Send document: Send the release authorization for secure signing. Archive record: Store the completed authorization with its audit trail.
What the audit trail records
The audit trail documents identity, timing, integrity, and retrieval events for each Authorization To Release Confidential Substance Use Disorder Treatment.
Authenticate signer:
Capture timestamp:
Hash document:
Seal record:
Log activity:
Export evidence:
Choose the right signing method
- Use the signNow web app when staff prepare the authorization, assign roles, and monitor completion from a desktop workflow.
- Use the mobile app when a patient or authorized representative needs to review and sign from an iOS or Android device.
- Use kiosk mode for supervised, in-person completion when staff control the signing device and recipient access.
- Use a shareable signing link when an approved recipient needs controlled access without a separately addressed email invitation.
- Best ROI. Our customers achieve an average 7x ROI within the first six months.
- Scales with your use cases. From SMBs to mid-market, airSlate SignNow delivers results for businesses of all sizes.
- Intuitive UI and API. Sign and send documents from your apps in minutes.
Recommended authorization workflow setup
Use a controlled signing configuration that protects treatment information, records signer intent, and preserves the authorization for the applicable retention period.
| Setting | Recommendation |
|---|---|
| Authentication method | SMS verification for authorized recipients |
| Signature type | Intent-based electronic signature |
| Audit trail | Retain completion history and signer actions |
| Document retention | Six years under HIPAA 45 CFR §164.530(j) |
| Encryption | AES-256 at rest and TLS 1.2/1.3 in transit |
Find and fill out the correct authorization to release confidential substance use disorder treatment
airSlate SignNow helps you fill in and sign documents in minutes, error-free. Choose the correct version of the editable PDF form from the list and get started filling it out.
| Versions | Form popularity | Fillable & printable |
|---|---|---|
| WA CHPW Authorization to Release Confidential Substance Use Disorder Treatment Information 2019 | 4.8 Satisfied (234 Votes) | |
| WA CHPW Authorization to Release Confidential Substance Use Disorder Treatment Information 2017 | 4.7 Satisfied (177 Votes) |
Protect confidential treatment information
Health information:
Security reporting:
Security management:
Stored records:
Data transfer:
Privacy controls:
Avoid privacy and disclosure mistakes
Including diagnoses or treatment details beyond the authorization’s stated purpose can expose unnecessary protected health information. Missing the recipient, purpose, expiration, or permitted information scope can make the release ambiguous and difficult to apply. Sending the completed authorization to an unintended email address can disclose confidential substance use disorder treatment information. Granting broad workspace access without role controls can let unauthorized staff view or download signed release records.
Best practices for signed authorizations
Careful scope, evidence preservation, retention, and access review reduce disclosure risk when handling this treatment-release authorization.
Specify the permitted disclosure
Preserve the evidence package
Apply the HIPAA retention rule
Review access before sending
Retention periods for related records
Retention depends on the record category surrounding the authorization. Apply the rule that actually governs the record, and check state requirements before deletion.
Six years for HIPAA records
Three years for tax records
Later I-9 retention period
Three years for payroll records
Five years for injury records
Know document and state-law limits
State notarization
Wills and codicils
Court orders
Family law
Troubleshoot signing and compliance issues
Resolve access, authentication, evidence, consent, plan, and retention questions before releasing confidential treatment information.
The Business plan provides legally binding eSignatures, templates, audit trails, and mobile apps. For treatment-related information, confirm that your organization has the required HIPAA configuration and a Business Associate Agreement before sending protected health information.
A 7-day free trial is available without a credit card. Business costs $8 per user per month when billed annually, while Business Premium costs $15 and adds bulk send and kiosk mode.
If a signer cannot open the authorization, verify the email address, resend the invitation, or provide a controlled signing link. The sender should confirm that the recipient is authorized to receive the treatment information.
Use signNow’s audit trail to review timestamps, signer actions, and completion history. Under ESIGN and UETA, admissibility depends on intent, consent, attribution, and the ability to retain and reproduce the record.
For patient-facing electronic records, provide the ESIGN consumer disclosure when applicable, explain the right to paper records, and maintain procedures for withdrawing electronic consent under 15 U.S.C. §7001(c).
HIPAA requires covered entities to retain required policies, procedures, and documentation for six years from creation or the last effective date under 45 CFR §164.530(j). Confirm whether state law or another record category requires longer retention.
Key performance indicators that demonstrate SignNow's proven track record.
BE READY TO GET MORE
Get this form now!
If you believe that this page should be taken down, please follow our DMCA take-down process.